(3-(2-Methoxy-2-oxoethyl)phenyl)boronic acid, 95.0%, 100mg

1-(3-Bromo-4-methoxyphenyl)-2,2,2-trifluoroethan-1-ol, 95%, 500mg

N-(2,5-Dimethoxyphenyl)-2-chloropropanamide, 98%, 10g

1-Methyl-1h-imidazole-2-sulfonamide, 97%, 250mg

Bolsas de eliminación SEKUROKA® PP, 50 ?m, 600 x 800 mm, 100 unidades

DL-Malic acid di-n-butyl ester, 98%, 25g

(3-(Bromomethyl)phenyl)(phenyl)methanone, 95.0%, 25g

1-[1-(4-bromophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-chloroethanone, 95.0%, 250mg

7-Amino-6-methoxy-2,3-dihydro-1H-inden-1-one, 97.0%, 250mg

N,N-Dimethylazetidin-3-amine dihydrochloride, 95.0%, 100g

(3R,4R)-1-(TERT-BUTOXYCARBONYL)-3-(4-CHLOROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID, 95%, 1g

2-((2R,3R)-4-(Anthracen-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)pyridine, 97%, 250mg

[(2S)-1-methylazetidin-2-yl]methanamine; bis(trifluoroacetic acid), 95.0%, 1g